FDT is efficient for monitoring functional damage in OAG patients
Frequency doubling technology (FDT) is successful in monitoring functional damage in the standard automated perimetry (SAP)-normal hemifield in eyes with open-angle glaucoma (OAG).
Frequency doubling technology (FDT) is successful in monitoring functional damage in the standard automated perimetry (SAP)-normal hemifield in eyes with open-angle glaucoma (OAG), states a study in the Journal of Glaucoma.
Dr Suguru Nakagawa et al. Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Gifu, Japan, performed the investigation on 39 OAG patients with low to normal intraocular pressure (IOP).
The Humphrey Field Analyzer was used to measure FDT perimetry with the N-30 full threshold protocol and SAP. This was used along with the 30-2 Swedish Interactive Threshold Algorithm-standard protocol for at least 3 years in all patients.
A linear mixed model was employed to measure time courses of the mean of the FDT threshold values and mean total deviations (TDs) in SAP-normal and abnormal fields.
The findings demonstrated a significantly negative change in the mean FDT threshold values in the SAP-normal hemifield. However, the mean changes in TD values by SAP were not statistically significant.
SAP-abnormal hemifield experienced a significantly more negative change in the mean TD values, but FDT threshold values presented with no significant differences between the two hemifields.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
